Pharmadax Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced sales was TWD 70.749 million compared to TWD 4.139 million a year ago. Operating loss was TWD 90.454 million compared to TWD 105.594 million a year ago. Net loss was TWD 83.158 million compared to TWD 106.784 million a year ago. Basic loss per share was TWD 1.32 compared to TWD 1.83 a year ago. For the nine months, sales was TWD 183.905 million compared to TWD 21.859 million a year ago. Operating loss was TWD 246.208 million compared to TWD 332.545 million a year ago. Net loss was TWD 242.037 million compared to TWD 322.596 million a year ago. Basic loss per share was TWD 3.95 compared to TWD 5.53 a year ago.